“ I wish to mold my career into becoming one of the thought leaders for cellular immunotherapy directed at lymphomas, and the LRF will be playing an indispensable role in providing me with avenues to achieve that goal.”

Raghuveer Ranganathan, MD

University of North Carolina, Chapel Hill